← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Targepeutics, Inc.
Hershey, PA
$629,785
Total funding
3
Grants
Funding over time
peak $275K · FY2011–23$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$629,785 · 3
By mechanism
R43$430,000 · 2
N43$199,785 · 1
Investigators at Targepeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of GB13 for the Treatment of Pediatric Diffuse Intrinsic Pontine Glioma$275,000
R43 · FY2022 · CA
TAS::75 0849::TAS TOPIC 255 DEVELOPMENT OF GB13 AS A NOVEL GLIOBLASTOMA THERAPY$199,785
N43 · FY2011 · CA
GLIOBLAST-13: A NOVEL ANTI-BRAIN TUMOR THERAPEUTIC$100,000
R43 · FY2000 · CA
Development of GB13 for the Treatment of Pediatric Diffuse Intrinsic Pontine Glioma$55,000
R43 · FY2023 · CA